Picture of Oncolys Biopharma logo

4588 — Oncolys Biopharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Table: Oncolys Biopharma -2019 parent results

Feb 7 (Reuters)- 
          Oncolys Biopharma Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to       NEXT   
              Dec 31, 2019     Dec 31, 2018   Dec 31, 2020     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           1.30           168 mln                                
              (+673.5 pct)     (-26.4 pct)                              
  Operating   loss 511 mln      loss 1.25                               
  Recurring   loss 539 mln      loss 1.23                               
  Net         loss 912 mln      loss 1.23                               
  EPS        loss 65.55 yen  loss 104.55 yen                            
  Ann Div          NIL             NIL             NIL                  
  -Q2 Div          NIL             NIL             NIL                  
  -Q4 Div          NIL             NIL             NIL                  
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T

Recent news on Oncolys Biopharma

See all news